The announcement of a class action lawsuit against Humacyte, Inc. for alleged securities law violations is likely to negatively impact investor sentiment and cause short-term stock price volatility. Legal issues can lead to uncertainty and potential financial liabilities, which typically result in downward pressure on stock prices.